Case Reports in Oncological Medicine
Scope & Guideline
Innovating cancer treatment through real-world experiences.
Introduction
Aims and Scopes
- Clinical Case Reports:
The journal emphasizes detailed clinical case reports that provide insights into unique presentations or rare manifestations of cancers, enhancing the knowledge base of oncologists. - Multidisciplinary Approaches:
It showcases cases involving multidisciplinary treatment strategies, highlighting the importance of collaboration among various specialists in managing complex oncological cases. - Innovative Treatment Strategies:
The journal frequently discusses novel therapies and their outcomes, including the use of targeted therapies, immunotherapies, and other emerging treatment modalities. - Pathological Insights:
Pathological analyses and findings play a crucial role in the reports, often leading to discussions on the implications for diagnosis and prognosis. - Patient-Centered Outcomes:
There is a consistent focus on patient outcomes, including quality of life and treatment efficacy, which are critical for informing future clinical practices.
Trending and Emerging
- Immunotherapy and Checkpoint Inhibitors:
There is a growing number of case reports addressing the effects and complications of immunotherapy, particularly immune checkpoint inhibitors, highlighting their significance in modern cancer treatment. - Genetic and Molecular Insights:
Emerging cases that delve into the genetic and molecular underpinnings of cancers are on the rise, reflecting a shift towards personalized medicine and targeted therapies. - Rare and Uncommon Tumors:
The focus on rare tumor types and unusual presentations is trending, providing critical insights into less understood malignancies and their management. - Multimodal Treatment Approaches:
Increasingly, reports are showcasing combined treatment modalities (e.g., surgery, chemotherapy, and radiotherapy), emphasizing a comprehensive approach to complex oncology cases. - Patient-Specific Treatment Responses:
There is a trend towards documenting individual patient responses to specific treatments, which is vital for understanding the variability of treatment efficacy and guiding future clinical decisions.
Declining or Waning
- Traditional Chemotherapy Case Reports:
There has been a noticeable decline in the publication of case reports solely focusing on traditional chemotherapy regimens, as newer treatment modalities gain traction and become the focus of clinical discussion. - Palliative Care Case Studies:
Fewer case reports are dedicated to palliative care approaches, suggesting a shift towards curative or innovative treatment discussions in oncology. - Basic Science Reports:
Reports that primarily focus on basic science or laboratory findings related to oncology are less common, indicating a preference for clinical applications and case-related insights. - Epidemiological Studies:
There is a decrease in the publication of case reports centered around epidemiological data, possibly as more comprehensive studies and reviews are published elsewhere. - Generalized Cancer Types:
The journal has shifted away from more generalized cancer types, focusing instead on rarer cancers and unique presentations that offer novel insights.
Similar Journals
Case Reports in Dermatology
Enhancing collaboration and education in dermatological research.Case Reports in Dermatology is a leading Open Access academic journal dedicated to the publication of case reports and unique clinical findings in the field of dermatology. Published by KARGER and based in Switzerland, the journal has been an open access resource since 2009, enhancing the visibility and accessibility of vital research for dermatology professionals and the scientific community. With an impressive ISSN of 1662-6567 and ranking in the Q3 category among dermatological journals, it serves as a crucial platform for researchers seeking to share innovative case studies, validate diagnostic approaches, and explore treatment outcomes. The journal continues to contribute to advancing dermatological science with a convergence timeline extending from 2010 to 2024. By promoting the dissemination of emerging knowledge and practices, Case Reports in Dermatology plays a significant role in fostering collaboration among practitioners, enhancing educational efforts, and ultimately improving patient care in dermatology.
Translational Oncology
Empowering Researchers to Impact Oncology OutcomesTranslational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.
Acta Oto-Laryngologica Case Reports
Fostering Collaboration in Otolaryngology with Open Access InsightsActa Oto-Laryngologica Case Reports, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to the dissemination of high-quality case reports in the field of otolaryngology. Since its inception in 2016, this journal has been a vital platform for researchers and clinicians to share unique clinical insights and advancements related to ear, nose, and throat disorders. With an ISSN of 2377-2484, it provides unparalleled access to the latest findings, facilitating collaboration and innovation among professionals in otolaryngology. The journal's commitment to open-access publishing ensures that critical research is freely available to a global audience, enhancing the visibility and impact of its contributors' work. Researchers, practitioners, and students in the medical field will find valuable resources and case studies that not only contribute to professional development but also address current challenges in patient care.
Revista Colombiana de Cancerologia
Transforming Cancer Treatment with Cutting-edge ResearchRevista Colombiana de Cancerologia is a premier journal dedicated to advancing the field of oncology in Colombia and beyond. Published by the Instituto Nacional de Cancerología, this journal serves as a vital platform for the dissemination of high-quality research, comprehensive reviews, and innovative methodologies pertinent to cancer research and treatment. With an ISSN of 0123-9015 and E-ISSN 2346-0199, it aims to engage a diverse audience, including researchers, healthcare professionals, and students, fostering collaboration and knowledge sharing within the oncology community. Although specific metrics such as impact factors and H-index are currently unavailable, the journal is committed to maintaining high academic standards and encouraging open access to vital oncological insights. The Revista Colombiana de Cancerologia is positioned as an essential resource for those interested in the latest advancements in cancer care, prevention, and research methodologies, making significant contributions to the understanding and management of cancer.
BMJ Case Reports
Elevating Clinical Insights Through Unique Case StudiesBMJ Case Reports is a vital resource within the field of medicine, published by the esteemed BMJ PUBLISHING GROUP. With an E-ISSN of 1757-790X and a focus on disseminating high-quality case reports, this journal serves as a platform for healthcare professionals, researchers, and students to share unique clinical experiences and uncommon presentations of medical conditions. Since its inception in 2008 and continuing through 2024, it has gained recognition for contributing to the advancement of medical knowledge, currently ranking at Q4 in the Medicine (miscellaneous) category and positioned in the 54th percentile in General Medicine according to Scopus rankings. Although it is a subscription-based journal, its impact on clinical practice and education is significant, enabling practitioners to learn from diverse case studies and improving patient care outcomes. As it aims to enhance the understanding of rare and significant medical cases, BMJ Case Reports remains an essential publication for those at the forefront of medical innovation.
Journal of Kidney Cancer and VHL
Unlocking insights into renal health challenges.The Journal of Kidney Cancer and VHL stands as a leading platform for disseminating cutting-edge research in the field of renal oncology, particularly focused on kidney cancer and Von Hippel-Lindau (VHL) disease. Published by CODON PUBLICATIONS since its inception, this Open Access journal, with ready accessibility since 2014, aims to foster knowledge exchange and collaboration among researchers, clinicians, and healthcare professionals dedicated to improving outcomes for patients with kidney cancer. With an ISSN of 2203-5826, this journal serves as a vital resource in the academic community, encouraging submissions that span various topics, including epidemiology, treatment modalities, and innovative therapeutic strategies. By providing unrestricted access to its content, the Journal of Kidney Cancer and VHL promotes inclusive participation in the global dialogue surrounding these critical health challenges, ensuring that the latest findings reach all corners of the scientific community.
SAGE Open Medical Case Reports
Empowering Healthcare Through Open InsightsSAGE Open Medical Case Reports, published by SAGE Publications Inc, is a pioneering open-access journal dedicated to the rapid dissemination of medical case reports that significantly contribute to clinical knowledge and practice. Since its launch in 2013, this journal has become a valuable resource for healthcare professionals, researchers, and students in the field of medicine, facilitating the exchange of unique clinical experiences from around the globe. While the journal is categorized as Q4 in the Medicine (miscellaneous) quartile and holds a Scopus rank of 423 out of 636 in the General Medicine category, the accessibility of its content underscores its commitment to enhancing medical education and informing practice. With no subscription barriers, it supports the sharing of critical insights appropriate to a diverse audience, thereby fostering a culture of innovation and collaboration in healthcare.
Leukemia Research Reports
Pioneering open access to vital leukemia insights.Leukemia Research Reports, published by Elsevier Advanced Technology, is a prominent open-access journal dedicated to the latest advancements in the field of hematology and oncology. Since its launch in 2012, this journal has been a vital resource for researchers, healthcare professionals, and students aiming to disseminate and access high-quality research articles focused on various aspects of leukemia and related blood disorders. With an impact factor indicative of its significance in the field, Leukemia Research Reports currently holds a Q3 quartile ranking in both Hematology and Oncology, and is included in key databases such as Scopus. The journal not only embraces a commitment to open access, ensuring that research is freely available, but also actively promotes collaborations that strive to enhance our understanding and treatment of leukemia. Based in the United Kingdom, this journal continues to play a crucial role in fostering innovation and knowledge sharing within the medical community.
ACG Case Reports Journal
Elevating Medical Practice Through Shared ExperiencesACG Case Reports Journal, published by Lippincott Williams & Wilkins, is a pivotal resource in the realm of gastrointestinal medicine and clinical practice. Since its inception in 2014, this open-access journal has dedicated itself to disseminating high-quality case reports that contribute to the evolving understanding of gastrointestinal diseases and their management. With an impressive ranking of #203 out of 529 in the General Medicine category according to Scopus, placing it in the 61st percentile, the journal underscores its significant role in advancing medical knowledge. This accessibility allows researchers, healthcare professionals, and students to engage with groundbreaking case studies, enriching their expertise and promoting informed clinical decision-making. ACG Case Reports Journal aims to foster a collaborative environment where innovative ideas and clinical experiences converge, ultimately enhancing patient care and outcomes in the field of gastroenterology.
Rare Tumors
Championing rare tumor research for a brighter future.Rare Tumors, published by SAGE Publications Ltd, is a premier open-access journal dedicated to advancing the understanding and research of rare neoplasms. With the ISSN 2036-3605 and E-ISSN 2036-3613, this journal provides a vital platform for sharing innovative research findings and clinical insights since its inception in 2009. Situated in Italy, Rare Tumors has a converged publication timeline from 2010 to 2024 and aims to foster a supportive community for researchers and professionals in the oncology and histology fields. It has achieved a notable Q3 ranking in Oncology and Q4 in Histology as of 2023, reflecting its crucial role in bridging the knowledge gap in these specialized areas. Despite its relatively humble Scopus ranks, the journal's open-access model ensures that vital information reaches a broad audience, including those in academia, clinical practice, and beyond. It aspires to not only document rare tumor cases but also stimulate dialogue on their diagnosis, treatment, and management strategies, making it an indispensable resource for anyone dedicated to tackling the challenges posed by rare tumors.